Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
Zachariah L Dorey-Stein, Kartik V Shenoy Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USACorrespondence: Zachariah L Dorey-SteinDepartment of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, 3401...
Saved in:
Main Authors: | Dorey-Stein ZL (Author), Shenoy KV (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dupilumab and tezepelumab in severe refractory asthma: new opportunities
by: Beatrice Ragnoli, et al.
Published: (2022) -
Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
by: Paul C Langley
Published: (2022) -
Biological treatment options for severe asthma in Poland
by: Maciej Superson, et al.
Published: (2024) -
Unconventional Treatment Options in Severe Asthma: An Overivew
by: Hoan Linh Banh
Published: (2011) -
Severe refractory asthma: current treatment options and ongoing research
by: Francesco Menzella, et al.
Published: (2018)